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This study aims to obtain secondary metabolites that have antibacterial activity from bacteria
endophytic of ascidian Pycnoclavella diminuta collected from the coast of Bitung, North
Sulawesi, Indonesia. The research was started with screening antibacterial activity of six
bacteria isolated from P. diminuta. The active bacteria were selected for identification
using standard biological molecular method and further fermentation to produce
secondary metabolites. The isolation of secondary metabolites was conducted by various
chromatography method and then selected fraction was based on the antibacterial activity
from bioautography results. The result showed that the active isolate by coding M2.Tnk.Bt
5.10-3.2 was identified as Vibrio sp. The potential active fraction was further sub-fractionated
by HPLC semi-preparative and each of these sub-fractions was tested against Staphylococcus
aureus, Bacillus cereus, Enterococcus faecalis, Eschericia coli, and Vibrio cholerae. The
test results showed that all 17 sub-fractions were active against Gram-positive bacteria S.
aureus and B. cereus, and only one sub-fraction (SFr 2) showed antibacterial activity against
E. faecalis. Whereas in Gram-negative bacteria, 2 sub-fractions (SFr 12 and SFr 13) showed
antibacterial activity against E. coli and 12 sub-fractions active against V. cholerae. GC-MS
analysis of the SFr 2 sub-fraction showed the presence of fifteen phytochemical constituents
with a major compound Pyrrolo [1,2-a] pyrazine-1,4-dione, hexahydro-3- (2 methylpropyl).
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INTRODUCTION
Infectious diseases caused by microorganisms continue
to increase every year and become a challenge faced
by the global community (Smith et al., 2014). The
rising number of infectious diseases is caused by the
evolution of microbial pathogens that are resistant to
existing antibiotics (Lupetti et al., 2002). The emergence
of widespread resistant bacteria has led researchers to
explore new alternative antibacterial agents from natural
sources to be developed as new drugs (Walsh, 2003;
Viejo-Diaz et al., 2005).
Recently, marine ecosystems have attracted attention as
a potential new source for natural bioactive compounds
(Kjer et al., 2010). The oceans, which cover more than
70% of our planet’s surface with all its uniqueness and
biodiversity, consist of abundant types of microbes
(Bugni & Ireland, 2004; König et al., 2006). Marine
microorganisms have demonstrated the diversity of
secondary metabolites that can be produced. Many new
secondary metabolites have been reported with a wide
E-ISSN 2477-0612

range of biological activity. The extreme conditions
resulted from competition between bacteria in the marine
environment arise due to harsh chemical and physical
environmental conditions, adaptation to different
habitats and environments with high levels of stress,
such as cold temperature, high pressure and little/no
light, that cause these microorganisms naturally required
to synthesize secondary metabolites that can be used as
a weapon of defense and competition (Nikapitiya, 2012;
Zheng et al., 2005). Therefore, marine creatures are
prospective to produce a variety of new compounds with
unique structural and chemical properties with higher
biological activity than terrestrial creatures, so that they
have a huge potential for the pharmaceutical industry
(Nikapitiya, 2012).
Ascidian or tunicata is of one of the marine invertebrates
from which thousands of metabolites have been
successfully isolated and it produces many bioactive
compounds with various bioactivity. Several studies
have proven that some secondary metabolites isolated
from ascidian are of symbiotic microorganism origin
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(Davidson, 1993; Schmidt & Donia, 2010). Several
findings on the secondary metabolites have shown a wide
range of biological activity from ascidian-associated
marine microorganisms including the activity as an
antibacterial agent (Wyche et al., 2012; Ellis et al., 2014).
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The marine biodiversity off the coastlines of Indonesia’s
many islands offers a tremendous opportunity to
investigate potential antimicrobial compounds from
both the marine invertebrates and the microorganisms
that they carry (Putra et al., 2016a; Putra et al.,
2016b). Nonetheless, information on pharmacological
activities from Indonesian ascidians and associated
microorganisms is still limited. Here, we report a study
on secondary metabolites produced from a species of
Vibrio that is associated with the ascidian Pycnoclavella
diminuta collected from the coast of Bitung in North
Sulawesi, Indonesia.

mL Erlenmeyer flask in a shaker (29 °C/150 rpm) for 24
h. This seed culture (10 mL each) was then transferred
to ten 2 L Erlenmeyer flask containing 1 L with same
medium and cultured with shaking (150 rpm) for 4
days at 29 °C. The fermentation broth was extracted
using ethyl acetate and the extract was concentrated by
evaporation. The ethyl acetate extract was fractionated
by vacuum liquid chromatography using on a silica gel
column with elution performed on a gradient system of
increasing polarity from n-hexane to EtOAc to Acetone
to MeOH. Each fraction was collected and evaporated
for bioautography assay. The active fraction was further
subjected to HPLC semi-preparative using isocratic
elution with acetonitrile:H2O (35:65) (flow rate 2 mL/
min, Agilent C18 (10 x 250 mm), UV-Vis at 254 nm).
The different fractions were collected and concentrated
by evaporation. The concentrated fractions were tested
for antibacterial assay to identify the active fraction.

METHODS

Antibacterial Activity Assay

Sample Collection
Strain M2.Tnk.Bt 5.10-3.2 was isolated from ascidian
Pycnoclavella diminuta collected from the coast of
Bitung, North Sulawesi, Indonesia at a depth of 5-10
m by SCUBA diving. It has been deposited in the
strain collection of Research Center for Oceanography,
Indonesian Institute of Sciences, Indonesia.

Bioautography
Antibacterial activity of the fraction was carried out using
the bioautography technique as previously described
by Valle Jr et al. (2016) with slight modifications. The
fractions were spotted on the GF254 silica gel TLC plate
and eluted with three different eluent systems as follows:
FA (n-heksan:CHCl3; 3,5:1,5), FB (CHCl3:Acetone;
4:1), FC and FD (CHCl3:MeOH; 4,5:1,5). Then, the TLC
plate was observed under UV light at 254 wavelengths
to determine the separation profile of each fraction.
Furthermore, the TLC plate was placed aseptically to
the media which had previously been inoculated with
the bacteria tested (Staphylococcus aureus ATCC 6538
and Eschericia coli ATCC 8739) for 60 minutes so that
the active compound on the TLC plate was transferred
by diffusion into the media. Then, the TLC plate was
removed and the agar plate was incubated at 37 °C for
18-24 h. The growth inhibition zones were observed and
compared with TLC plate Rf value result.

Identification of the Bacteria Strain
Strain identification was carried out by molecular
taxonomy using 16S rRNA gene sequencing. A single
colony was sub-cultured in Marine Broth at 29 °C
for 48 h. Genomic DNA was extracted following the
protocol described by Presto™ Mini gDNA Bacteria Kit
(Geneaid Biotech Ltd). Amplification of the 16S rRNA
was performed using MyTaq Red Mix (Bioline) with
specific primers 27F: AGAGTTTGATCMTGGCTCAG
and
1492R:
TACGGYTACCTTGTTACGACTT.
Polymerase chain reaction was performed in a 25 µL
mix reaction containing 9.5 µL dd H2O, 12.5 µL 2x
MyTaq Red Mix, 20 µmol/µL 27F Primer, 20 µmol/µL
1492R Primer and DNA Template. The PCR condition
as follows 35 cycles of 95 °C for 15 s (denaturation),
52 °C for 15 s (annealing), 68 °C for 45 s (extension).
PCR products purification with Zymoclean™ Gel DNA
Recovery Kit (Zymo Research). The resulting sequence
was then analyzed using BLAST and compared with
nucleotide on the National Center for Biotechnology
Information (NCBI) database.
Cultivation, Extraction, and Isolation
A seed culture of the strain M2.Tnk.Bt 5.10-3.2 was
prepared by inoculation of 50 mL medium (starch 20
g, glucose (Merck) 10 g, peptone 5 g, yeast extract 5
g and CaCO3 (Merck) 5 g in 1 liter seawater) in a 100

Agar diffusion method
The sub-fraction results were conducted using agar
diffusion method (CLSI, 2012). The bacteria tested
(Staphylococcus aureus ATCC 6538, Bacillus cereus
ATCC 11778, Enterococcus faecalis, Eschericia coli
ATCC 8739 and Vibrio cholerae) were prepared by
turbidimetry using UV-Vis spectrophotometer at a
wavelength of 625 nm to obtain absorbance between
0.08-0.12, which is equivalent to the standard 0.5
McFarland solution, and inoculated in sterile petri dish
by streaking the cotton swab sterile on the surface of
the MHA (Mueller-Hinton Agar) media. The procedure
was repeated by rotating the petri dish up to 60° to the
bacterial suspension evenly on the entire surface of the
Mueller-Hinton agar medium. After 3-5 min, aliquots of
E-ISSN 2477-0612
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Figure 1. Bioautography results; (a) Fraction A against S. aureus;
(b) Fraction B against S. aureus; (c) Fraction C against S. aureus; (d)
Fraction D against S. aureus; (e) Fractions A and B against E. coli;
(f) Fractions C and D against E. coli
20 µL of each sub-fraction samples were pipetted on to
filter paper disc of 6 mm diameter that had been placed
on the surface of the media. Then they were incubated
at 37 °C for 18-24 h. The chloramphenicol disc 30 µg/
disc (Oxoid) was used as a positive control and solvent
(DMSO 10%) was used as a negative control.
GC-MS analysis of subfraction
Active sub-fraction based on antibacterial activity testing
was characterized by GC-MS analysis by injecting 5 µL
sample into HP Ultra 2 Capillary Column (30 m x 0.2
mm i.d, 0.11 µm film thickness) of GC-MS (Agilent
Technologies 7890 Gas Chromatograph with autosampler
and 5975 Mass Selective Detector and Chemstation Data
System), with helium (1.2 mL/min) used as a carrier gas.
A temperature gradient program was applied with the
initial temperature at 80 °C hold for 0 minute, rising at
3 °C/min to 150 °C, hold for 1 minute and finally rising
20 °C/min to 280 °C, hold for 26 min. The resulting m/z
peaks (mass to charge ratio), which were characteristic
of active sub-fractions, were compared to the spectrum
library of corresponding organic compounds.

E-ISSN 2477-0612

RESULTS AND DISCUSSION
Identification of the Bacteria Strain
The isolate of M2.Tnk.Bt 5.10-3.2 showed high homology
to Vibrio sp. M-137-19 (99% sequence similarity).
Identification result that was carried out on M2.Tnk.
Bt 5.10-3.2 confirmed several previous studies, which
showed the predominance of Gram-negative bacteria in
the marine environment and also reported 36% of Gramnegative bacteria as an antibiotic producer (Fenical, 1993;
Bernen, 1997). Vibrio sp. bacteria show its dominance
in marine ecosystems and some previous studies have
shown this type of species to produce various types of
secondary metabolites, which have antibacterial activity
(Okada et al., 2005; Al-Zereini et al., 2010; Liaw et al.,
2015).
Antibacterial Activity
The fractionation process by vacuum liquid
chromatography produced 13 fractions, which were
then monitored by Thin Layer Chromatography (TLC).
Based on the same TLC separation pattern, 4 fraction
combinations were obtained (FA, FB, FC and FD).
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Table 1. Antibacterial activity of sub-fractions
Zone of Inhibition (mm)

Sample

Concentration
(µg/disk)

SA

BC

EF

EC

VC

SFr 1
SFr 2
SFr 3
SFr 4
SFr 5
SFr 6
SFr 7
SFr 8
SFr 9
SFr 10
SFr 11
SFr 12
SFr 13
SFr 14
SFr 15
SFr 15A
SFr 16
CHL

18
150
38
10
24
20
22
10
14
28
16
18
12
10
18
10
12
30

7.65 + 0.35
10.85 + 0.77
10.95 + 2.05
9.6 + 0.28
10.7 + 1.13
7.45 + 1.06
9.2 + 2.26
8.95 + 0.35
9.35 + 0.92
9.1 + 1.41
9.55 + 0.49
8.75 + 0.92
9.2 + 0.28
8.25 + 1.62
7.7 + 0.14
7.95 + 0.49
8.9 + 1.98
30.45 + 1.48

8.35 + 0.35
8.75 + 0.92
7.85 + 1.20
7.05 + 0.21
10 + 0.14
7.1 + 0.42
8.85 + 2.75
8.55 + 1.48
9.8 + 1.27
10.55 + 0.21
9.9 + 0.42
11.25 + 0.63
9.15 + 1.06
7.2 + 0.56
7.8 + 0.70
8.5 + 0.42
10.15 + 2.33
21.35 + 0.70

0
8.85 + 0.49
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18.4 + 0

0
0
0
0
0
0
0
0
0
0
0
6.95 + 0.07
6.75 + 0.35
0
0
0
0
23.05 + 1.48

0
10.3 + 1.13
10.55 + 0.63
11.9 + 1.13
11.9 + 2.54
0
11.15 + 0.35
0
9.55 + 1.20
0
9.75 + 0.77
10.1 + 0.56
8.35 + 1.34
9.85 + 2.47
9.45 + 0.35
0
11.15 + 0.49
39.1 + 2.40

Results (shown as mean + SD), CHL (Chloramphenicol), SA (S. aureus), BC (B. cereus), EF (E. faecalis), EC (E. coli), VC (V. cholerae)

These fractions were further tested for antibacterial
activity using bioautography (Fig 1). Bioautography is
applied as the preliminary antibacterial assay in order to
determine the presence or absence of activity (Choma
& GrZelak, 2011). In the preliminary screening, test
strains (Staphylococcus aureus and Eschericia coli)
were chosen to represent each group of Gram-positive
bacteria and Gram-negative bacteria, respectively. The
results showed the fraction B (FB) have antibacterial
activity against S. aureus at Rf value (0.75). The fraction
A (FA) also formed an inhibition zone against the S.
aureus, but the Rf value could not be determined due to
the separation pattern was not good enough on the TLC
plate. Whereas against E. coli, no inhibition zone was
formed for all fraction.
Based on the bioautography results, FB was chosen to be
sub-fractionated further using HPLC semi-preparative.
The separation process was achieved for 25 min and it
obtained 17 sub-fractions (SFr 1 - SFr 16). The fractions
obtained were evaluated to determine antibacterial activity using agar diffusion method (Table 1). The results
of the antibacterial activity of 17 sub-fractions against
Gram-positive bacteria showed the antibacterial activity
that characterized by the formation of inhibitory zones
in both S. aureus and B. cereus, but only sub-fraction of
SFr 2 showed the inhibitory zone against E. faecalis. In

the antibacterial activity assay of 17 sub-fractions against
Gram-negative bacteria, not all sub-fractions showed activity against Gram-negative bacteria. Only sub-fraction
of SFr 12 and SFr 13 showed inhibition activity against
E. coli and 12 sub-fractions (SFr 2, SFr 3, SFr 4, SFr 5,
SFr 7, SFr 9, SFr 11, SFr 12, SFr 13, SFr 14, SFr 15 and
SFr 16) showed activity against V. cholerae.
The sub-fractions obtained were more active against
Gram-positive bacteria than Gram-negative bacteria.
This difference could be due to the cell wall structure
of Gram-negative bacteria, which is more complex than
that of Gram-positive bacteria, the membrane accumulation mechanisms in Gram-negative bacteria, or the
mechanism of destruction of molecules introduced from
the outside, that is caused by the presence of enzymes in
the periplasmic space (Motamedi et al., 2010). Besides
that, the difference results could be caused by different
concentration from each sub-fractions.
GC-MS Analysis
The identification of sub-fraction SFr 2 was achieved
by GC-MS to determine the type of compounds that
produced antibacterial activity. SFr 2 was selected
based on the yield that was more representative for
analyzing further than other sub-fractions. Figure 2
E-ISSN 2477-0612
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Figure 2. Gas chromatogram of SFr 2 profile

Figure 3. Chemical Structure and EI-MS spectrum of Pyrrolo [1,2-a]
pyrazine-1,4-dione, hexahydro-3-(2 methylpropyl)
showed the chromatogram of SFr 2 with the dominant
peak with the highest abundance at retention time of
28.864 min (peak area 48.34%). Based on the GC-MS
library record at that retention, it was confirmed that the
molecular weight of the compound was 210, and the
molecular formula was determined as C11H18N2O2, which
was identified as Pyrrolo [1,2-a] pyrazine-1,4-dione,
hexahydro-3- (2-methylpropyl) (PPDHMP). The EI-MS
spectrum of SFr 2 indicated ions at 70 (M-C7H10NO2)
and 154 (M-C4H8) (Fig 3). The fragmentation pattern
of the spectrum has similarities to the EI-MS spectrum
obtained in the previous study by Guo et al. (2015).
Based on the results, the PPDHMP was suggested as the
main constituent of SFr 2 that could contribute to the
antibacterial activity. This compound was previously
isolated from Vibrio parahaemolyticus and from
endophytic fungi Penicillium sp. (Fdhila et al., 2003;
Pandey et al., 2010; Devi & Wahab, 2012). Other
chemical compounds detected by GC-MS were identified
(Table 2). Some of the fatty acids with small quantities

E-ISSN 2477-0612

were tetradecanoic acid (1.26%) and oleic acid (6.71%),
which have been reported to have antibacterial activity
(Huang et al., 2010; Dilika et al., 2000; Yoon et al.,
2018).
CONCLUSION
The secondary metabolite from Vibrio sp. shows promise
as a potential source of the antibacterial compound.
GC-MS analysis of the SFr 2 sub-fraction revealed
the presence of fifteen phytochemical constituents
with a major compound Pyrrolo [1,2-a] pyrazine-1,4dione, hexahydro-3- (2 methylpropyl). Isolation of
pure compounds and optimization of the production of
secondary metabolites should be carried out further.
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Table 2. Phytochemicals of the SFr 2 sub-fraction
Compound Identified

Retention Time (min)

Peak Area (%)

Phenol, 2-methoxy
Propane, 2-chloro
Phenol, 2,6-dimethoxy
Benzoid acid, 4-hidroxy-3-methoxy
Tetradecanoic acid
2-isopropyl-5-methylcyclohexamine
Prolylleucyl anhydride
Pyrrolo [1,2-a] pyrazine-1,4-dione,
hexahydro-3-(2-metylpropyl)
9-octadecenoic acid (z)
Oleic acid
9-octadecenoic acid (z)
8-hexadecenal, 14-methyl-, (z)
1, 8, 15, 22-tetraaza-2, 7, 16, 21-cyclooctacosanetetrone
Pyridine-3-carboxamide, oxime,
N-(2-trifluoromethylphenyl)
2-hydroxy-1-(hyroxymethyl) ethyl
(9z)-9-octadecenoate

5.952
7.124
14.088
24.686
27.238
27.803
28.672

1.18
0.82
0.75
2.02
1.26
3.87
9.79

28.865

48.34

29.623
30.010
31.085
31.389

0.95
6.71
3.31
4.44

31.851

4.85

33.505

10.59

36.960

1.12
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